<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8809320</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1600</journal-id>
<journal-id journal-id-type="nlm-ta">Neuron</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuron</journal-id>
<journal-title-group>
<journal-title>Neuron</journal-title>
</journal-title-group>
<issn pub-type="ppub">0896-6273</issn>
<issn pub-type="epub">1097-4199</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26938441</article-id>
<article-id pub-id-type="pmc">4793939</article-id>
<article-id pub-id-type="doi">10.1016/j.neuron.2016.02.024</article-id>
<article-id pub-id-type="manuscript">NIHMS764213</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>De Novo</italic> Synonymous Mutations in Regulatory Elements Contribute to the Genetic Etiology of Autism and Schizophrenia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Takata</surname>
<given-names>Atsushi</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN2">6</xref>
<xref ref-type="author-notes" rid="FN4">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ionita-Laza</surname>
<given-names>Iuliana</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gogos</surname>
<given-names>Joseph A.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Bin</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN2">6</xref>
<xref ref-type="author-notes" rid="FN3">7</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Karayiorgou</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="author-notes" rid="FN3">7</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Psychiatry, Columbia University Medical Center, New York, NY 10032, USA</aff>
<aff id="A2"><label>2</label>Department of Biostatistics, Columbia University Medical Center, New York, NY 10032, USA</aff>
<aff id="A3"><label>3</label>Department of Neuroscience, Columbia University Medical Center, New York, NY 10032, USA</aff>
<aff id="A4"><label>4</label>Department of Physiology &amp; Cellular Biophysics, Columbia University Medical Center, New York, NY 10032, USA</aff>
<aff id="A5"><label>5</label>New York State Psychiatric Institute, New York, NY 10032, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Correspondence to Maria Karayiorgou (<email>mk2758@cumc.columbia.edu</email>) or Bin Xu (<email>bx2105@cumc.columbia.edu</email>)</corresp>
<fn fn-type="equal" id="FN2">
<label>6</label>
<p>These authors contributed equally to this work</p>
</fn>
<fn id="FN3">
<label>7</label>
<p>Co-senior authors</p>
</fn>
<fn fn-type="present-address" id="FN4">
<label>8</label>
<p>Present address: Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute, Saitama, 351-0198, Japan</p>
</fn>
<fn fn-type="conflict" id="FN6">
<p>
<bold>COMPETING FINANCIAL INTERESTS</bold>
</p>
<p>The authors declare no competing financial interests.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>5</day>
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>2</day>
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>02</day>
<month>3</month>
<year>2017</year>
</pub-date>
<volume>89</volume>
<issue>5</issue>
<fpage>940</fpage>
<lpage>947</lpage>
<!--elocation-id from pubmed: 10.1016/j.neuron.2016.02.024-->
<abstract id="Abs1">
<title>SUMMARY</title>
<p id="P1">We analyze <italic>de novo</italic> synonymous mutations identified in autism spectrum disorders (ASD) and schizophrenia (SCZ) with potential impact on regulatory elements using data from whole exome sequencing (WES) studies. Focusing on five types of genetic regulatory functions, we found that <italic>de novo</italic> near-splice site synonymous mutations changing exonic splicing regulators and those within frontal cortex-derived DNase I hypersensitivity sites are significantly enriched in ASD and SCZ, respectively. These results remained significant, albeit less so, after incorporating two additional ASD datasets. Among the genes identified, several are hit by multiple functional <italic>de novo</italic> mutations, with <italic>RAB2A</italic> and <italic>SETD1A</italic> showing the highest statistical significance in ASD and SCZ, respectively. The estimated contribution of these synonymous mutations to disease liability is comparable to <italic>de novo</italic> protein-truncating mutations. These findings expand the repertoire of functional <italic>de novo</italic> mutations to include “functional” synonymous ones and strengthen the role of rare variants in neuropsychiatric disease risk.</p>
</abstract>
<abstract abstract-type="graphical" id="Abs2">
<title>eTOC Blurb</title>
<p id="P2">The role of <italic>de novo</italic> non-synonymous mutations in neuropsychiatric disorders is well established. In this study, Takata et al. explore the role of a different class of genetic variants, synonymous or “silent” mutations, and discover that they too contribute to autism and schizophrenia by affecting regulatory elements.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>